Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ARCT

Arcturus Therapeutics (ARCT)

Arcturus Therapeutics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARCT
FechaHoraFuenteTítuloSímboloCompañía
07/12/202022:30Business Wire Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/12/202016:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/12/202015:33Business WireArcturus Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/12/202015:16Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/12/202006:00Business WireArcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) DeficiencyNASDAQ:ARCTArcturus Therapeutics Holdings Inc
07/12/202005:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
03/12/202016:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
30/11/202017:00Business WireArcturus Therapeutics to Present at Upcoming Investor ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/11/202015:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/11/202015:01Business WireArcturus Therapeutics Announces Third Quarter 2020 Financial Results & Positive Clinical Updates for ARCT-810 Phase I Study &...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/11/202006:00Business WireArcturus Therapeutics Announces Positive Interim ARCT-021 (LUNAR-COV19) Phase 1/2 Study Results for Both Single Shot & Prime-...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/11/202007:00Business WireArcturus Therapeutics to Present at Upcoming Investor and Scientific ConferencesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
30/10/202008:00Business WireArcturus Therapeutics to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Nov 9, 2020NASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/10/202007:00Business WireArcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic C...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/10/202007:00Business WireArcturus Therapeutics to Present at Guggenheim’s Vaccines and Infectious Diseases ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
11/09/202015:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/09/202009:31GlobeNewswire Inc.Arcturus Therapeutics Announces Preclinical Publication of its COVID-19 Vaccine CandidateNASDAQ:ARCTArcturus Therapeutics Holdings Inc
18/08/202008:00GlobeNewswire Inc.Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of HealthNASDAQ:ARCTArcturus Therapeutics Holdings Inc
11/08/202007:01GlobeNewswire Inc.Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (AR...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
10/08/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate UpdateNASDAQ:ARCTArcturus Therapeutics Holdings Inc
06/08/202007:30GlobeNewswire Inc.Arcturus Therapeutics Appoints Lance Kurata as Chief Legal OfficerNASDAQ:ARCTArcturus Therapeutics Holdings Inc
05/08/202005:10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
04/08/202007:30GlobeNewswire Inc.Arcturus Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020NASDAQ:ARCTArcturus Therapeutics Holdings Inc
31/07/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
28/07/202023:30GlobeNewswire Inc.Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common StockNASDAQ:ARCTArcturus Therapeutics Holdings Inc
23/07/202015:01GlobeNewswire Inc.Arcturus Therapeutics Announces Agreement with Israeli Ministry of Health to Supply COVID-19 Vaccine Candidate, LUNAR-COV19NASDAQ:ARCTArcturus Therapeutics Holdings Inc
21/07/202007:30GlobeNewswire Inc.Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, L...NASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/07/202005:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARCTArcturus Therapeutics Holdings Inc
01/07/202007:00GlobeNewswire Inc.Arcturus Therapeutics Announces the Formation of its Vaccine Platform Scientific Advisory BoardNASDAQ:ARCTArcturus Therapeutics Holdings Inc
29/06/202007:00GlobeNewswire Inc.Arcturus Therapeutics to be Added to Russell 2000® IndexNASDAQ:ARCTArcturus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ARCT

Su Consulta Reciente

Delayed Upgrade Clock